- Salarius Pharmaceuticals Inc at Ladenburg Thalmann Healthcare Conference TranscriptSep 29, 2022
- Q2 2022 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022€35.92 (+6.21%)Earnings
- Q1 2022 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022€47.2 (+31.55%)Earnings
- Q4 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptMar 10, 2022€70 (+4.17%)Earnings
- Salarius Pharmaceuticals Inc Asset Acquisition Agreement with DeuteRx LLC - M&A Call TranscriptJan 13, 2022
- Q3 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptNov 04, 2021€144 (+0.70%)Earnings
- Salarius Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- Q2 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021€136Earnings
- Salarius Pharmaceuticals Inc Virtual KOL & Investor Event Call TranscriptJun 21, 2021
- Q1 2021 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2021€194 (+0.52%)Earnings
- Q4 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptMar 18, 2021€256 (+1.59%)Earnings
- Salarius Pharmaceuticals Inc to Discuss Advancements in the Phase 1/2 Clinical Trial of Seclidemstat Conference Call TranscriptFeb 24, 2021
- Q3 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptNov 11, 2020€124 (+5.08%)Earnings
- Q2 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2020€171 (-11.40%)Earnings
- Q1 2020 Salarius Pharmaceuticals Inc Earnings Call TranscriptMay 14, 2020€152 (+2.01%)Earnings
- Salarius Pharmaceuticals Inc at SNN Network TranscriptNov 20, 2019
Salarius Pharmaceuticals Inc at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
All right. Let's move on to our next -- -t seems like we're going back and forth this mroning. We're doing eyes, oncology, eyes, oncology, eyes, oncology. We're going back to oncology here with our next presentation, Salarius Pharmaceuticals. David Arthur is the CEO, and his team here. Guys, let's bring David on.
David? There he is. How are we doing? Good morning.
Good morning, Spencer. Thanks for having us. And I'm glad that you're getting lots of oncology companies in here today.
Yes. Well, yeah. The day is young yet. The day is young. We have the whole rest of the day, we got you, guys, we got tomorrow. But yeah, we're talking oncology, we're talking everything here at the Benzinga Small Cap Healthcare Conference. So that being said, I'm going to bring on your slides, and there they are. I'm going to step back stage and I'm going to give you the floor, sir, to tell us all about
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)